i ve subscribed for 1 lakh. lets see what happens.. hope for the best.... its seems we wil get full allotement. @all expert here what say for this ipo ????????????
The issue has been subscribed 1.5 times, reports CNBC-TV18. Reserved portion of retail investors, qualified institutional and non-institutional investors got subscribed 1.4 times, 1.3 times and 2 times, respectively.
Meanwhile, Claris has already received commitment for Rs 54 crore through key investors' portion as against offering of 18,43,003 equity shares at Rs 293 a share - at higher end of price band of Rs 278-293.
Claris is one of the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Products offering comprises 113 products across multiple markets and therapeutic areas.
I have seen results WRT Pharma Market....It should give better return ..since share allocation will be on Higher side so amount Invested Vs Return Recd Could be better than other issues invested
AS PER 'ET NOW' TV-CHANNEL CLARIS IPO OVERSUBSCRIBED -1.6 TIMES AS OF 4.00 PM. EXPECT SOME NICE PREMIUM IF MARKETS SUSTAIN. HAPPY LISTING TO THOSE WHO APPLIED!
Prabhudas Lilladher, Nirmal Bang, Mehta Equities, Angel Broking and KRChoksey have given "Subscribe" recommendation.
I would like to know whether there is any way to find out how many shares each of these "Experts" or Brokerage houses they are working for have subscribed to
If all of them have implemented their own suggestions instead of just giving "Free Advices" with Disclaimer clauses, the IPO would not have become a flop
At 1 pm IST, very poor subscription by FII on both claris & SCI issues. I beleive they are sensible in giving a big thumbsup to MOIL and leving the other two becoz of pricing and promoter issues.
what are the chances of the operators playing with this stock...do u think they will use the refund of moil to play with this or return it back to moil on listing day?